Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Experimental Dermatology|December 22, 2007
Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanomaJürgen Eberle, Lothar F Fecker, Amir M Hossini, et al.
Journal of Virology|October 7, 2011
Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell lineSandra Pinkert, Karin Klingel, Vanessa Lindig, et al.
Journal of Visualized Experiments : Jove|November 3, 2016
Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2Thomas Hiller, Viola Röhrs, Eva-Maria Dehne, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenovirusesAlmudena Hurtado Picó, Xiaomin Wang, Isaac Sipo, et al.
International Journal of Molecular Sciences|July 29, 2025
Sensitivity of Pancreatic Cancer Cell Lines to Clinically Approved FAK Inhibitors: Enhanced Cytotoxicity Through Combination with Oncolytic Coxsackievirus B3Anja Geisler, Babette Dieringer, Leslie Elsner, et al.
Human Gene Therapy|May 10, 2018
Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal CarcinomaAhmet Hazini, Markian Pryshliak, Vanessa Brückner, et al.
Pageof 8